Direct cell fate conversion of human somatic stem cells into cone and rod photoreceptor-like cells by inhibition of microRNA-203

• Published in: Oncotarget Vol. 7; no. 27; pp. 42139 - 42149
• Main Authors: Choi, Soon Won, Shin, Ji-Hee, Kim, Jae-Jun, Shin, Tae-Hoon, Seo, Yoojin, Kim, Hyung-Sik, Kang, Kyung-Sun
• Format: Journal Article
• Language: English
• Published: United States Impact Journals LLC 05.07.2016
• Subjects: Adult Stem Cells - cytology; Cell Differentiation - physiology; Cell Lineage; Gene Expression Regulation, Developmental; Homeodomain Proteins - genetics; Humans; MicroRNAs - metabolism; Neurons - cytology; Recombinant Proteins - metabolism; Research Paper; Retina - cytology; Retinal Cone Photoreceptor Cells - metabolism; Retinal Rod Photoreceptor Cells - cytology; miR-203; AESC; UCB-MSC; neural retina; photoreceptor
• ISSN: 1949-2553; 1949-2553
• DOI: 10.18632/oncotarget.9882

Stem cell-based photoreceptor differentiation strategies have been the recent focus of therapies for retinal degenerative diseases. Previous studies utilized embryonic stem (ES) cells and neural retina differentiation cocktails, including DKK1 and Noggin. Here, we show a novel microRNA-mediated strategy of retina differentiation from somatic stem cells, which are potential allogeneic cell sources. Human amniotic epithelial stem cells (AESCs) and umbilical cord blood-derived mesenchymal stem cells (UCB-MSCs) treated with a retina differentiation cocktail induced gene expressions of retina development-relevant genes. Furthermore, microRNA-203 (miR-203) is abundantly expressed in human AESCs and human UCB-MSCs. This miR-203 is predicted to target multiple retina development-relevant genes, particularly DKK1, CRX, RORβ, NEUROD1, NRL and THRB. The inhibition of miR-203 induced a retina differentiation of AESCs and UCB-MSCs. Moreover, successive treatments of anti-miR-203 led to the expression of both mature photoreceptor (PR) markers, rhodopsin and opsin. In addition, we determined that CRX, NRL and DKK1 are direct targets of miR-203 using a luciferase assay. Thus, the work presented here suggests that somatic stem cells can potentially differentiate into neural retina cell types when treated with anti-miR-203. They may prove to be a source of both PR subtypes for future allogeneic stem cell-based therapies of non-regenerative retina diseases.